Find Rovadicitinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1948242-59-8, A4v35p6kws, (3r)-3-[3-amino-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-3-cyclopentylpropanenitrile, (3r)-3-(3-amino-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)-3-cyclopentylpropanenitrile, Refchem:1098160, Rovadicitinib [inn]
Molecular Formula
C17H19N7
Molecular Weight
321.4  g/mol
InChI Key
ZGENDZDSLYKCSI-CQSZACIVSA-N
FDA UNII
A4V35P6KWS

Rovadicitinib
ROVADICITINIB is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.
1 2D Structure

Rovadicitinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R)-3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-3-cyclopentylpropanenitrile
2.1.2 InChI
InChI=1S/C17H19N7/c18-7-5-14(11-3-1-2-4-11)24-9-13(16(19)23-24)15-12-6-8-20-17(12)22-10-21-15/h6,8-11,14H,1-5H2,(H2,19,23)(H,20,21,22)/t14-/m1/s1
2.1.3 InChI Key
ZGENDZDSLYKCSI-CQSZACIVSA-N
2.2 Other Identifiers
2.2.1 UNII
A4V35P6KWS
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1948242-59-8

2. A4v35p6kws

3. (3r)-3-[3-amino-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-3-cyclopentylpropanenitrile

4. (3r)-3-(3-amino-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)-3-cyclopentylpropanenitrile

5. Refchem:1098160

6. Rovadicitinib [inn]

7. Chembl5314485

8. Schembl17858699

9. Gtpl12384

10. Us10561657, Example 5

11. Bdbm433327

12. Glxc-27915

13. Example 5 [us10561657b2]

14. Da-77542

15. Hy-148798

16. Cs-0641156

17. (3r)-3-[3-amino-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- Pyrazol-1-yl]-3-cyclopentylpropanenitrile

18. (betar)-3-amino-beta-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazole-1-propanenitrile

19. 1h-pyrazole-1-propanenitrile, 3-amino-beta-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-, (betar)-

2.4 Create Date
2016-08-06
3 Chemical and Physical Properties
Molecular Weight 321.4 g/mol
Molecular Formula C17H19N7
XLogP31.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area109
Heavy Atom Count24
Formal Charge0
Complexity483
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty